Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a government-funding/status notice and upgraded version to v3.2.0; removed the old v3.1.0 tag.SummaryDifference3%
- Check21 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element has been removed; overall content remains essentially the same.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant changes in its location listings, with the addition of new facility names and locations in Tuscany and Navarre, while also removing previous location details. Additionally, the version number has been updated.SummaryDifference1%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.